Immunotherapy outcome in advanced/metastatic lung cancer patients in real-world experience: Indian data

被引：0
|
作者：
K, N. [1 ]
Singh, A. C. [1 ]
Noronha, V. [1 ]
Joshi, A. P. [1 ]
Patil, V. M. [1 ]
Menon, N. S. [1 ]
Prabhash, K. [1 ]
机构：
[1] Tata Mem Hosp Parel, Med Oncol, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
547P
引用
收藏
页码：S1683 / S1683
页数：1
相关论文
共 50 条
  • [21] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Kim, Mijin
    Ahn, Jonghwa
    Song, Dong Eun
    Yoon, Jee Hee
    Kang, Ho-Cheol
    Lim, Dong Jun
    Kim, Won Gu
    Kim, Tae Yong
    Kim, Won Bae
    Shong, Young Kee
    Jeon, Min Ji
    Kim, Bo Hyun
    ENDOCRINE, 2021, 71 (02) : 427 - 433
  • [22] Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
    Mijin Kim
    Jonghwa Ahn
    Dong Eun Song
    Jee Hee Yoon
    Ho-Cheol Kang
    Dong Jun Lim
    Won Gu Kim
    Tae Yong Kim
    Won Bae Kim
    Young Kee Shong
    Min Ji Jeon
    Bo Hyun Kim
    Endocrine, 2021, 71 : 427 - 433
  • [23] Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
    Acedo, Rocio Diaz
    Banqueri, Mercedes Galvan
    Criado, Silvia Artacho
    Parra, Eva Maria Fernandez
    Galan, Rocio Jimenez
    Sanchez, Ana Isabel Gago
    Pozo, Juan Francisco Marin
    Bautista, Maria Jose Martinez
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 382 - 389
  • [24] Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
    Rocío Díaz Acedo
    Mercedes Galvan Banqueri
    Silvia Artacho Criado
    Eva María Fernández Parra
    Rocío Jiménez Galán
    Ana Isabel Gago Sánchez
    Juan Francisco Marín Pozo
    María José Martínez Bautista
    International Journal of Clinical Pharmacy, 2024, 46 : 382 - 389
  • [25] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [26] Brazilian real-world data of immunotherapy in extensive stage small cell lung cancer
    Duarte, Flavia A.
    Dienstmann, Rodrigo
    Diniz, Paulo H. C.
    Silva, Matheus C. e
    Veloso, Gilson G. V.
    Arcanjo, Georgia S.
    Paes, Rafael
    Montella, Tatiane C.
    Lima, Helena F. C. A.
    Ferrari, Bruno L.
    Macuzo, Eliane V.
    Ferreira, Carlos G.
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [27] Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia
    Nishimura, Ari
    Hamauchi, Satoshi
    Notsu, Akifumi
    Fushiki, Kunihiro
    Oshima, Kotoe
    Tsushima, Takahiro
    Kawakami, Takeshi
    Todaka, Akiko
    Yokota, Tomoya
    Yasui, Hirofumi
    Onozawa, Yusuke
    Yamazaki, Kentaro
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [28] Immunotherapy in advanced mismatch repair deficiency endometrial cancer: A real-world single center experience
    Rauthan, A.
    Murthy, N. Y.
    Patil, P.
    Prasannakumar, S. Sampige
    Zaveri, S.
    Ashwath, R.
    Vundemodalu, P.
    Jomi, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S1513 - S1513
  • [29] Clinical Outcomes of Immunotherapy with or without Radiation in Advanced Lung Cancer: a Real-World, Retrospective Study
    Liang, J.
    Zhu, L.
    Wu, K.
    Zhang, J.
    Chen, X.
    Xia, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S636 - S636
  • [30] Using Real-world Data to Define a Validated Nomogram for Advanced Bladder Cancer Patients Who Respond to Immunotherapy
    Elumalai, T.
    Croxford, W.
    Buijtenhuijs, B.
    Conroy, R.
    Sanderson, B.
    Enting, D.
    Aversa, C.
    Doss, G.
    Das, A.
    Vasudev, N. S.
    Kitetere, E.
    Tolan, S.
    Law, A.
    Hoskin, P.
    Mistry, H.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2022, 34 (10) : 642 - 652
12345